Risovalisib

DB21474InvestigationalSmall molecule

Risovalisib is a small molecule drug. Risovalisib is under investigation in clinical trial NCT05043922 (A Study to Evaluate the Efficacy and Safety of CYH33 in Patients With Recurrent/Persistent Ovary Clear... Risovalisib has a monoisotopic molecular weight of 598.19 Da.

Formula / weight: C₂₄H₂₉F₃N₈O₅S · 598.6 g/mol (avg)
Code names: CYH-33

Resolves to

Compound

UNIIRCA38L4HB5CAS1494684-28-4ChEMBLCHEMBL4800252ChEBI758451PubChem72550012

Structure

InChIKeyKTLQDDGRBDLKMN-UHFFFAOYSA-NSMILESCOC(=O)NC1=CC(=C(C=N1)C1=NN2C=C(CN3CCN(CC3)S(C)(=O)=O)C=C2C(=N1)N1CCOCC1)C(F)(F)F

Targets

P42336PIK3CA

What you can answer from here — as of September 23, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

5Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Risovalisib, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account